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Abstract: Ventricular tachycardia although not common, can occasionally complicate pregnancy. Its presence may indicate an   underlying 
cardiac  structural  abnormality,  or  undiagnosed  congenital  arrhythmic  disease.  However,  some  pregnant  patients  with    ventricular 
  tachycardia have structurally normal hearts. Two cases of ventricular tachycardia in pregnant patients with structurally normal hearts 
are presented and an approach to diagnosis and management of such patients are discussed.
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case 1
A 33-year-old woman, (gravida 3, para 2), at 34 weeks 
of gestation, presented with episodes of lightheadedness, 
and dyspnea. She was asymptomatic until 18 weeks 
of  gestation,  when  she  started  having    episodes  of 
palpitations associated with presyncope. Initially, the 
  episodes were infrequent (less than once per day) but 
a gradual increase in frequency and severity was noted 
by the patient. One month prior to presentation, she 
noted episodes of paroxysmal nocturnal dyspnea, but 
no dyspnea on exertion, chest pain, diaphoresis, pedal 
edema, orthopnea, or neurological symptoms.
She had no significant past medical history and had 
not had complications relating to this pregnancy. All 
prior pregnancies had progressed to full term without 
similar symptoms or complications, and resulted in 
spontaneous vaginal deliveries of healthy newborns. 
The patient was using no medications except multi-
vitamins. There was no history of smoking, alcohol 
consumption or illicit drug use.
Physical examination revealed an afebrile patient 
with a regular pulse of 80 beats per minute, blood 
pressure  110/70  mmHg,  and  an  oxygen  saturation 
of 100% on room air. The examination was normal 
except for mild non-pitting edema and fine bibasilar 
crackles.
Laboratory investigations revealed normal   complete 
blood count, electrolytes, renal function, cardiac mark-
ers  and  TSH.  Cardiac  monitoring  showed  multiple 
episodes  of  monomorphic,  non-sustained  ventricular 
tachycardia (VT) with left bundle branch morphology, 
consistent with VT originating from the right ventricu-
lar outflow tract (Fig. 1). These episodes occurred both 
at rest and with ambulation. Urgent two-dimensional 
echocardiogram showed normal left ventricular size and 
wall thickness with no segmental wall motion abnor-
malities and normal systolic and diastolic function with 
a left ventricular ejection fraction of 57%. There were 
no valvular abnormalities. A 12-lead electrocardiogram 
showed sinus rhythm with average rate of 80 beats/min 
with a normal axis, PR-interval, and QRS duration with 
no evidence of chamber enlargement or infarction. The 
clinical working diagnosis was pregnancy-related VT 
of right ventricular outflow tract origin.
case 2 
A 24 year woman (gravida 4, para 2) presented to her 
local emergency department at 24 weeks gestation 
because of shortness of breath, cough, and chest tight-
ness developing over the previous day. There were 
no other cardiorespiratory symptoms. Her pregnancy 
had been progressing normally.
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Figure 1. telemetry cardiac rhythm recording of patient 1 (lead I), showing wide complex tachycardia at a rate of 160 bpm.Ventricular tachycardia in pregnancy
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She had a history of mild asthma but had not had 
asthma-related symptoms for several years and had 
never had an asthma exacerbation requiring inpatient 
or emergency department care. Past medical history 
and  family  history  were  otherwise  unremarkable. 
There had been no similar symptoms or medical com-
plications in her previous three pregnancies, one of 
which had ended with spontaneous abortion and the 
other two with term delivery of healthy children.
The patient was using no medications. She lived 
with her husband and two children. She smoked one-
half to one pack of cigarettes per day but did not drink 
alcohol or use recreational drugs.
Physical examination revealed an afebrile patient 
with a regular pulse of 78 beats per minute, blood 
pressure  100/60  mmHg,  and  an  oxygen  saturation 
of 96% on room air. On respiratory exam she was 
slightly tachypneic and had expiratory wheezes. The 
rest of the examination was normal except for mild 
non-pitting peripheral edema.
Laboratory  investigations  revealed  normal  com-
plete  blood  count,  electrolytes,  renal  function,  car-
diac markers, and TSH. Cardiac monitoring showed 
ventricular trigeminy. The patient was diagnosed with 
an  asthma  exacerbation  and  treated  with  nebulized 
salbutamol  2.5  mg,  which  relieved  her  symptoms. 
Shortly thereafter, she developed runs of asymptom-
atic nonsustained VT with a left bundle branch block 
pattern (Fig. 2). Her shortness of breath recurred later 
in the day. Nebulized salbutamol 5 mg was once again 
administered, whereupon the patient developed sus-
tained runs of VT of similar morphology. Intravenous 
lidocaine and magnesium sulfate were administered, 
leading to resolution of the ventricular arrhythmia. The 
patient was transferred to the coronary care unit of our 
hospital. No further salbutamol was   administered, and 
two   further days of electrocardiographic   monitoring 
showed only occasional PVCs. Twelve lead electro-
cardiogram showed sinus   tachycardia at 102 beats per 
minute with occasional premature ventricular beats, 
normal  corrected  QT  interval  and  no  evidence  of 
ischemia or chamber enlargement. Echocardiography 
showed normal left ventricular size with normal sys-
tolic function with an ejection fraction of 57%, and no 
valvular abnormalities.
Given  the  absence  of  structural  heart  disease 
and risk factors for coronary disease or arrhythmia, 
the  clinical  diagnosis  was  catecholamine-sensitive 
  pregnancy-related VT of right ventricular outflow tract 
origin. The temporal relationship to salbutamol use 
suggests that this agent may have precipitated VT.
Discussion
Ventricular tachycardias (VT) may be seen in preg-
nancy and can manifest as a new onset arrhythmia or 
be exacerbated by pregnancy and can cause concern 
for the well-being of both the mother and the fetus. 
Ventricular tachycardia may manifest at any time dur-
ing pregnancy. A study of 11 pregnant women who 
experienced  a  new  onset  of  VT  during  pregnancy 
showed that onset was distributed equally over the 
three trimesters and disappeared completely during 
the postpartum period.1 The characteristics and under-
lying mechanisms of new-onset VT during pregnancy 
have not been adequately investigated. Although the 
majority  of  VTs  that  occur  during  the  pregnancy 
are benign, in women with structural heart disease, 
arrhythmias (especially those of ventricular origin) is 
one of the five independent predictors of having an 
adverse outcome during pregnancy.2,3
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Figure 2. telemetry cardiac rhythm recording of patient 2 (lead II), showing wide complex tachycardia at a rate of 150 bpm.Kotchetkov et al
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Peripartum cardiomyopathy (PPCM) needs to be 
considered in women presenting with VT in the last 
month of pregnancy.4,5 The criteria for the diagnosis 
of PPCM include: development of congestive heart 
failure secondary to left ventricular systolic dysfunc-
tion in the last month of pregnancy or within 5 months 
after delivery, absence of preexisting cardiac dysfunc-
tion, and absence of identifiable cause of heart failure 
and LV systolic dysfunction demonstrated by classic 
echocardiographic criteria.6 Hence in women present-
ing with VT in the last month of pregnancy, an urgent 
echocardiographic study can assist in establishing a 
diagnosis of PPCM.
Women  with  certain  types  of  congenital  heart 
  disease (CHD) either repaired or not, are particularly 
vulnerable  to VT.  For  example,  patients  with  pre-
vious surgeries for correction of tetralogy of Fallot 
may experience VT arising from the right ventricular 
outflow tract as a result of right ventricular volume 
overload due to decades of severe pulmonary regur-
gitation as a consequence of patch augmentation of 
the right ventricular outflow tract at the time of origi-
nal corrective surgery.7 A study of 28 female patients 
with repaired CHD demonstrated women with CHD 
had a significantly higher incidence of tachyarrhyth-
mia during pregnancy and in the postpartum period 
compared to controls.8
Congenital long QT syndrome (LQTS) is a heredi-
tary disorder of cardiac ion channels causing abnormal 
electrical activation of the heart.9 Women with congen-
ital LQTS may experience life-threatening polymor-
phic VT; however recent reports indicates that their 
incidence appears to be significantly increased during 
the  postpartum  period.10,11  Patients  with  congenital 
LQTS are particularly vulnerable to adverse arrhyth-
mic effects of electrolyte depletion (further prolonga-
tion of QT interval) a possible complication in some 
pregnant women with hyperemesis. Cautious use of 
mediations that may further prolong the QT interval is 
necessary in these individuals to avoid precipitation of 
polymorphic VT. In addition to cardiac diseases, sev-
eral systemic non-cardiac disorders, including severe 
electrolyte derangements, thyroid function abnormali-
ties, pulmonary embolism, anemia, and drug overdose 
may present with ventricular arrhythmias.
There  are  few  reports  of  new  onset VT  during 
pregnancy in absence of structural heart disease.12,13 
Increased sympathetic activity, as well as   physiological 
changes associated with normal pregnancy such as 
increased heart rate, decreased peripheral resistance, 
increased stroke volume and psychological stresses 
are thought to be the most common precipitants of 
VT in pregnant women with a structurally normal 
hearts.14,15 The majority of outflow tract VT in struc-
turally normal hearts originate from the Right Ventric-
ular Outflow Tract (RVOT) just below the pulmonary 
valve. This is also the most common focus of initia-
tion of pregnancy-related idiopathic VT and usually 
does not deteriorate to an unstable rhythm. It will 
often manifest as ectopic beats, bigeminal rhythms 
or short runs of non-sustained VT. Ventricular tachy-
cardia originating from the RVOT is associated with 
states of hormonal fluctuation. Increased norepineph-
rine concentration in the myocardial synaptic cleft 
has been suggested as a potential mechanism for this 
arrhythmia.16 Only 10% of VT originates from the 
Left Ventricular Outflow Tract (LVOT).17
To  make  a  diagnosis,  a  12-lead  ECG  should  be 
recorded ideally during the arrhythmia, although this 
can be difficult. A typical resting ECG of a pregnant 
woman may show an increased heart rate with decreased 
PR, QRS and QT intervals, but there is usually no sig-
nificant change in the amplitudes of P and T-waves and 
QRS-complex.15 Premature atrial and ventricular beats 
as well as Q wave and inverted T waves in the inferior 
leads can also be seen during pregnancy.18
On ECG, RVOT VT appears as wide QRS complex 
tachycardia with left bundle brunch block (LBBB) 
morphology and an inferior axis.17,19 Two phenotypic 
forms of RVOT VT can occur, non-sustained mono-
morphic VT and paroxysmal sustained VT.20 In con-
trast, LVOT VT morphology depends on the site of 
origin with either LBBB and early precordial transi-
tion in leads V1–2, or RBBB pattern in V1 with broad 
monophasic R in the precordial leads. In addition, the 
ECG in patients with VT originating in the LVOT 
will show R:S amplitude ratio of 30% or more or an 
R:QRS duration ratio of 50% in leads V1–2.21
A routine 24 to 48 hour-Holter monitor is   help- 
ful  in  capturing  frequently  occurring  paroxysmal 
arrhythmias. To elicit symptoms, an exercise ECG 
can be reasonably carried out during pregnancy in 
absence  of  obstetrical  contraindications  for  exer-
cise. Alternatively, a pharmacological challenge may Ventricular tachycardia in pregnancy
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  provide important diagnostic information. Adenosine 
has been safely used in pregnancy. No fetal adverse 
events are reported for adenosine, except for one case 
of transient fetal bradycardia.22
The  first  step  in  acute  management  of  VT  in 
  pregnancy to determine the hemodynamic stability of 
the pregnant woman. If the woman is unstable or there 
is evidence of significant fetal compromise which is 
thought to be related to the VT, DC cardioversion with 
50–100 J should be given immediately. DC shocks 
can be repeated at higher levels of energy (100–360 
J) if indicated. The risk for the fetus is minimal for all 
stages of pregnancy, because the amount of current 
reaching the fetus is small.23 In stable VT, an accu-
rate diagnosis of the type of arrhythmia should be 
made with a twelve-lead ECG prior to any interven-
tion. Invasive electrophysiological studies are rarely 
required during pregnancy, as the arrhythmias can be 
effectively managed pharmacologically.
Conservative medical treatment of VT arising dur-
ing pregnancy is indicated in any patient with sustained 
VT as long as the patient is hemodynamically stable.14 If 
possible drug therapy should be avoided during the 
first trimester and drugs with the longest records of 
safety should be used as the first-line therapies.24 The 
literature safety data has examined digoxin, adenosine, 
flecainide,  procainamide,  propranolol,  propafenone, 
quinidine, sotalol and verapamil, however; the experi-
ence is limited to single or small case series. In stable 
patients with sustained VT acute therapy can be ini-
tiated with either intravenous procainamide, which is 
safe, well-tolerated and is not associated with terato-
genicity. Alternatively Lidocaine can also be used to 
treat stable VT.14 Idiopathic VT originating from the 
RVOT and with a LBBB morphology responds well to 
beta-blockers, while idiopathic LVOT VT with RBBB 
morphology  generally  responds  well  to  verapamil. 
Given the sensitivity of majority of VTs in pregnancy 
to catecholamines, a cardioselective beta-blocker, in 
particular metoprolol, in the absence of contraindica-
tions is considered first line therapy.12
Return to the cases
In our cases, further investigations did not reveal a 
secondary cause of the patients’ arrhythmias. Based 
on  the  ECGs  (QRS  morphology  of  a  left  bundle 
branch block pattern with an inferior axis, and   clinical 
  findings) both patients were diagnosed with idiopathic 
VT originating from the RVOT.
Management  with  oral  metoprolol  at  25  and 
12.5 mg twice a day was initiated. The lower dose for 
the second patient was chosen because of suspected 
asthma exacerbation; however the dose was slowly 
increased to 50 mg PO every 12 hours. Both patients 
tolerated  treatment  well  and  had  no  further  docu-
mented episodes of VT on long-term cardiac monitor-
ing. Patient 1 was scheduled for elective C-section at a 
high risk obstetric center and was discharged home. On 
the follow-up she did not have further episodes of pal-
pitations or presyncopal/syncopal episodes. Patient 2 
had a spontaneous vaginal delivery at 36 weeks and 
continued to be on metoprolol after discharge.
conclusion
Pregnant patients may present with ventricular tachy-
cardia during any trimester Careful and timely clini-
cal, electrocardiographic, as well as echocardiographic 
assessment help identify those individuals with struc-
tural  cardiac  abnormalities  such  as  congenital  heart 
disease or peripartum cardiomyopathy, as well as those 
with long QT syndrome who will need specific man-
agement beyond therapy for the arrhythmia. In those 
stable patients with structurally normal hearts, identifi-
cation of the location of origin of tachycardia will help 
in choice of appropriate medical therapy.
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